secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2024-10-10T23:59:59+00:00
Accession:  0001493152-24-040757
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma ratifies exec salary hikes to $416K, $200K bonuses, and RSU grants
--------------------------------------------------------------------------------

- James Martin (CFO/co-CEO) and Dr. Sam Lee (President/co-CEO) base salary increased from $400K to $416K, plus $200K bonus and 40,000 RSUs each.
- Non-employee director grants: Dr. Kornberg $60.5K cash + $100K SAB stipend + 28,109 RSUs; Dr. Frost $44,770 + 27,100 RSUs; Steven Rubin $82,280 + 18,957 RSUs.
- Other director grants: Fred Hassan $36,300 + 8,067 RSUs; Richard Pfenniger $36,300 + 8,067 RSUs; Dr. Japour $54,450 + 14,924 RSUs.
- Half of each RSU grant vested immediately; remaining half vests quarterly over two years starting Sep 30, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000149315224040757/0001493152-24-040757-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000149315224040757/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-040757

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer